Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Income Statement [Abstract]
REVENUES	$ 3,398	$ 1,529
COST OF REVENUES	2,711	1,237
GROSS PROFIT	687	292
OPERATING EXPENSES:
Research and development	4,763	4,059
Selling and marketing	5,180	2,750
General and administrative	4,722	4,943
Total operating expenses	14,665	11,752
LOSS FROM OPERATIONS	(13,978)	(11,460)
FINANCIAL INCOME, net	289	294
NET LOSS	$ (13,689)	$ (11,166)
NET LOSS PER SHARE - basic	$ (0.16)	$ 0.22
NET LOSS PER SHARE - diluted	$ (0.16)	$ 0.22
WEIGHTED AVERAGE NUMBER OF COMMON STOCK USED IN COMPUTING NET LOSS PER SHARE - basic	83,801,839	49,993,509
WEIGHTED AVERAGE NUMBER OF COMMON STOCK USED IN COMPUTING NET LOSS PER SHARE - diluted	83,801,839	49,993,509